1 completed. 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 1 | Completed 1 |
Follow Jnj-56021927: new trials by email Literature Review of Jnj-56021927 trials Research Report on Jnj-56021927
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of Apalutamide in Chinese Participants With Non Metastatic Castration Resistant Prostate Cancer (NM-CRPC) Apalutamide, Placebo, Androgen-deprivation Therapy (ADT) - Prostatic Neoplasms | Phase 4 | Completed | Janssen Research & Development, LLC | 75 | 2019-12-17 | 2026-07-30 |
Janssen Research & Development, LLC (1)
China (1)